<?xml version="1.0" encoding="utf-8"?> 

<rss version="2.0"> 

<channel>

<title>LexisNexis&#174; Mealey's&#8482; Hormone Replacement Therapy Legal News</title>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

<description>Headline Hormone Replacement Therapy Legal News from LexisNexis&#174;</description>

<language>en-us</language>

<image>

<title>LexisNexis&#174; Headline Hormone Replacement Therapy Legal News</title>

<url>http://www.lexisnexis.com/mealeys/images/lexismealeyslogo.gif</url>

<width>130</width> 
  
<height>29</height>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

</image> 

<copyright>Copyright 2009</copyright>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>8th Circuit Upholds Woman's Prempro Verdict, Orders New Punitive Damages Trial</title>
<description>
<![CDATA[ST. LOUIS - The Eighth Circuit U.S. Court of Appeals on Nov. 2 affirmed a jury's $2.75 million compensatory damages award to a woman who claims that her use of Premarin, Prempro and Provera caused her to develop breast cancer and ordered a new trial on her punitive damages claim against Wyeth (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; 2009 U.S. App. LEXIS 23987; See September 2009, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Jury Awards Punitive Damages In Pa. Prempro Case, But Judge Seals Amount</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania state court jury on Oct. 26 ordered Prempro maker Wyeth Inc. to pay punitive damages to an Illinois woman who claims that her use of the hormone replacement therapy caused her to develop breast cancer, but the judge presiding over hormone replacement therapy mass tort proceedings ordered the amount sealed until the conclusion of a similar case in the same court (Connie Barton v. Wyeth Pharmaceuticals Inc., Case No. 040406301, Pa. Comm. Pls., Philadelphia Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Prempro MDL Judge Tentatively Schedules Punitive Damages, Bellwether Trials</title>
<description>
<![CDATA[LITTLE ROCK, Ark. - The federal judge presiding over the Prempro multidistrict litigation on Nov. 2 sent a letter to counsel tentatively scheduling the trial of a woman's punitive damages claim against Premarin and Prempro maker Wyeth for Feb. 2 and asked counsel to "pencil in" June 8 as the start of the next bellwether trial (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03cv1507, E.D. Ark.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Prempro MDL Plaintiffs Ask Judge To Start Remanding Cases For Trial</title>
<description>
<![CDATA[LITTLE ROCK, Ark. - Plaintiffs in the Prempro multidistrict litigation on Nov. 4 asked the judge presiding over the proceedings to remand to their transferor court lawsuits involving in extremis plaintiffs and cases where the plaintiffs have undergone case-specific discovery and to begin remanding 100 cases per month beginning in 2010 (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-cv-1507, E.D. Ark.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing MDL Judge Strikes Filing Of Master Complaint</title>
<description>
<![CDATA[ST. LOUIS - The federal judge presiding over the NuvaRing products liability multidistrict litigation on Oct. 23 decided to strike the master complaint from the docket because he did not expect the manufacturers of the contraceptive to seek dismissal of the complaint under Federal Rule of Civil Procedure 12(b) or appeal his ruling denying the motion (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Claims Asserted By Women Living In Different States Are Misjoined, Judge Rules</title>
<description>
<![CDATA[ST. LOUIS - Claims asserted by four women who did not live in Missouri but who are plaintiffs in a Missouri woman's lawsuit over injuries allegedly caused by their use of the NuvaRing contraceptive are misjoined because their causes of action do not arise out of the same transaction or occurrence, the federal judge presiding over the NuvaRing multidistrict litigation ruled Oct. 27 in dismissing without prejudice the claims of the non-Missouri residents (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, Jennifer Alday, et al. v. Organon USA Inc., No. 09CV1145, E.D. Mo.; 2009 U.S. Dist. LEXIS 100031). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Pill Maker Says Woman Has No Reasonable Possibility Of Success Against Pharmacy</title>
<description>
<![CDATA[EAST ST. LOUIS, Ill. - An Illinois woman's request to remand her products liability suit against the makers of Yaz and Yasmin and Walgreens Co. should be denied because there is no reasonable possibility of success on her claims against the pharmacy that dispensed the birth control pills, the manufacturers argue in an Oct. 21 brief (In re: Yaz and Yasmin (Drosperinone) Marketing, Sales Practices and Products Liability Litigation, MDL 2100, Case No. 09-md-2100, Kerry Sims v. Bayer Corp., et al., No. 09-CV-10012, S.D. Ill.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New Jersey Judge Files Application For Creation Of Yaz/Yasmin Mass Tort</title>
<description>
<![CDATA[TRENTON, N.J. - A New Jersey Superior Court judge on Oct. 22 sent a letter to the acting administrative director of the courts informing him that the number of cases involving injuries allegedly caused by the use of Yaz, Yasmin and Ocella warrants the creation of a mass tort proceeding in the state but did not offer any idea as to where the cases should be centralized (In re: Yaz/Yasmin and Ocella Products Liability Litigation, No. n/a, N.J. Super, Passaic Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Pharmacy Seeks Dismissal From Woman's Yaz/Yasmin Injury Lawsuit</title>
<description>
<![CDATA[EAST ST. LOUIS, Ill. - A pharmacy that filled an Illinois woman's prescription for Yaz and/or Yasmin moved for dismissal from her products liability suit in federal court on Oct. 9, arguing that she failed to state a claim against it (In re: Yaz and Yasmin (Drosperinone) Marketing, Sales Practices and products Liability Litigation, MDL 2100, Case No. 09-md-2100, Kerry Sims v. Bayer Corp., et al., No. 09-CV-10012, S.D. Ill.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>South Carolina Woman Says Yaz Caused Pulmonary Embolus, Gallstones</title>
<description>
<![CDATA[ATLANTIC CITY, N.J. - A South Carolina woman sued the makers of Yaz in New Jersey court on Oct. 21, alleging that her use of the birth control pill for less than six months caused her to suffer a pulmonary embolus and develop gallstones that required her to undergo a cholecystectomy to remove them (Candice Atkinson v. Bayer Corp., et al., No. L-ATL-3159-09, N.J. Super., Atlantic Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New York Firm Files 2 Complaints Alleging Injuries From Yaz/Yasmin</title>
<description>
<![CDATA[WHITE PLAINS, NY - The Great Neck, N.Y.-based law firm of Parker Waichman Alonso filed new complaints in New York federal court on Oct. 19 and 21 on behalf of a Georgia woman and a Tennessee woman, respectively, who claim that their use of the Yaz and Yasmin birth control pills caused them to suffer injuries (Tasha Marcell v. Bayer Corp., et al., No. 09 Civ. 8843, S.D. N.Y.; Judith Woodall v. Bayer Corp., et al., No. 09 Civ. 8931, S.D. N.Y.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-4 Mealeys Hormone Replacement Therapy 12%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Study: Breast Tenderness During HRT Use Linked With Higher Cancer Risk</title>
<description>
<![CDATA[CHICAGO - Researchers reviewing data from the Women's Health Initiative (WHI) study said in an article published in the Oct. 12 issue of Archives of Internal Medicine that women who experience breast tenderness while using hormone replacement therapy have nearly twice the risk of developing breast cancer compared with women whose breasts did not become tender while using the drugs. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-4 Mealey's Hormone Replacement Therapy 12 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Jury: Prempro Proximately Caused Breast Cancer; Woman Deserves $3.7 Million</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania Court of Common Pleas jury on Sept. 25 found that Prempro was a proximate cause of an Illinois woman's development of breast cancer and that she deserves $3.7 million in compensatory damages (Connie Barton v. Wyeth Pharmaceuticals Inc., Case No. 040406301, Pa. Comm. Pls., Philadelphia Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Parties In 5 N.J. HRT Cases Ordered To Submit More Choice-Of-Law Briefs</title>
<description>
<![CDATA[NEW BRUNSWICK, N.J. - The New Jersey judge presiding over the state's hormone replacement therapy mass tort litigation on Sept. 22 ordered parties in five cases where Wyeth has moved for summary judgment based on the statute of limitations to file additional briefing as to choice-of-law issues (In re: HRT Litigation, Case No. 266, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>JPMDL Centralizes Yaz/Yasmin Cases In Southern District Of Illinois</title>
<description>
<![CDATA[WASHINGTON, D.C. - The Judicial Panel on Multidistrict Litigation on Oct.1 created a multidistrict litigation for federal lawsuits involving injuries allegedly caused by the use of Yaz and Yasmin in the U.S. District Court for the Southern District of Illinois before Judge David Herndon (In re: Yaz/Yasmin Products Liability Litigation, MDL No. 2100, JPMDL). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Pennsylvania Judge Coordinates State Court Cases Involving Yaz, Yasmin And Ocella</title>
<description>
<![CDATA[PHILADELPHIA - A Pennsylvania state court judge on Sept. 16 signed an order coordinating proceedings in 14 cases filed in the Philadelphia County Court of Common Pleas by plaintiffs who allegedly sustained injuries as a result of using Bayer Corp.'s Yaz, Yasmin and Ocella birth control pills (In re: Yaz/Yasmin/Ocella Litigation, Sept. Term 2009, Case No. 1307, Pa. Comm. Pls., Philadelphia Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>2 Union Health Funds Say Bayer Unlawfully Marketed Yaz To Increase Sales</title>
<description>
<![CDATA[PHILADELPHIA - Two health funds for Philadelphia workers on Oct. 5 filed a class action suit in federal court against the makers of Yaz, alleging that the companies fraudulently and unlawfully marketed the oral contraceptive by overstating its safety and efficacy to increase sales (Philadelphia Firefighters Union Local No. 22 Health and Welfare Fund, et al. v. Bayer Healthcare Pharmaceuticals Inc., et al., No. 09-cv-4567, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Couple's Complaint Lacks Required Specificity, NuvaRing Maker Argues</title>
<description>
<![CDATA[ST. LOUIS - The makers of NuvaRing say in a Sept. 25 motion for judgment on the pleadings that a Wisconsin couple's lawsuit should be dismissed because the complaint fails to include any factual allegations to support a cause of action as required by the U.S. Supreme Court's rulings in Bell Atlantic v. Twombly (550 U.S. 544 [2007]) and Ashcroft v. Iqdal (129 S. Ct. 1937 [2009]) (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964; Kimberly Bryan, et al. v. Organon USA Inc., et al., No. 09-cv-1021-RWS, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Organon USA Says Complaint Fails To Meet Federal Pleading Requirements</title>
<description>
<![CDATA[ST. LOUIS - A North Carolina woman's NuvaRing products liability lawsuit should be dismissed, one of the makers of the contraceptive says in a Sept. 28 motion, because she fails to provide facts to support her claims and her fraud claims are not pleaded with particularity as required by Federal Rule of Civil Procedure 9 (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, Stephanie Holladay Dillon v. Organon USA Inc., et al., No. 09-cv-1608-RWS, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>New Jersey Ortho Evra Trial Rescheduled For May 2010</title>
<description>
<![CDATA[NEW BRUNSWICK, N.J. - The first bellwether trial in New Jersey's Ortho Evra mass tort proceeding has been rescheduled from April 2010 until May, according to a case management order entered Sept. 30 by the presiding New Jersey judge (In re: Ortho Evra Birth Control Patch Litigation, Case No. 275; Karlin Herring v. Johnson &amp; Johnson, No. L-5787-07, N.J. Super., Middlesex Co.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Allergan Wants Court To Find Off-Label Promotion Rules Are Unconstitutional</title>
<description>
<![CDATA[WASHINGTON, D.C. - Already under federal investigation for the off-label marketing of Botox, manufacturer Allergan Inc. on Oct. 1 asked a federal court to declare that federal regulations barring promotion of off-label uses of drugs are an unconstitutional violation of its First Amendment free speech rights (Allergan, Inc. v. United States of America, et al., No. 09-1879, D. D.C.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Study: HRT Use May Increase Risk Of Death From Lung Cancer</title>
<description>
<![CDATA[NEW YORK - The use of combination hormone replacement therapy may increase the risk of death from lung cancer in postmenopausal women using the drugs who already have the disease, according to a study published in the Sept. 20 online version of The Lancet. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-3 Mealeys Hormone Replacement Therapy 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>FDA Warns Bayer Over Testing Practices At German Plant</title>
<description>
<![CDATA[ROCKVILLE, Md. - The Food and Drug Administration on Sept. 15 issued a warning letter to the maker of the Yaz and Yasmin birth control pills over testing problems the agency witnessed during a March visit to the manufacturer's Berghamen, Germany, plant. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-3 Mealey's Hormone Replacement Therapy 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Court: Minnesota's Statute Of Limitations Applies To Nonresident's HRT Lawsuit</title>
<description>
<![CDATA[MINNEAPOLIS - Minnesota's six-year statute of limitations is applicable to a Pennsylvania woman's lawsuit alleging that her use of hormone replacement therapies made by Wyeth and Greenstone Ltd. caused her to develop breast cancer because the actions giving rise to her complaint arose before Aug. 1, 2004, the state's high court ruled Sept. 3 (Rachel Fleeger v. Wyeth, et al., No. A08-2124, Minn. Sup.; 2009 Minn. LEXIS 593; See March 2009, Page 9). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Prempro Plaintiff Says Expert's Use Of Differential Diagnosis Was Reliable</title>
<description>
<![CDATA[ST. LOUIS - A woman who was awarded $2.75 million in compensatory damages after a federal jury found that her use of hormone replacement therapies made by Wyeth and Pfizer Inc. subsidiary Pharmacia &amp; Upjohn caused her to develop breast cancer says in an Aug. 25 letter brief to the Eighth Circuit U.S. Court of Appeals that a ruling by the Viagra multidistrict litigation judge regarding the use of differential diagnosis should not be considered because her expert properly employed the methodology (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>HRT Makers Submit Viagra Causation Ruling To 8th Circuit</title>
<description>
<![CDATA[ST. LOUIS - The manufacturers of Premarin and Provera, who are seeking reversal of a $2.75 million compensatory damages verdict, on Aug. 21 submitted to the Eighth Circuit U.S. Court of Appeals a recent ruling from the Viagra multidistrict litigation judge to support their argument that differential diagnosis is an unreliable methodology for determining specific causation (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; See April 2009, Page 6). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Bayer Agrees That Yaz/Yasmin MDL Should Be Located In Ohio</title>
<description>
<![CDATA[WASHINGTON, D.C. - The maker of Yaz and Yasmin says in an Aug. 21 brief that it agrees with plaintiffs that cases involving injuries allegedly caused by the birth control pills should be centralized by the Judicial Panel on Multidistrict Litigation and that U.S. Judge James Carr of the Northern District of Ohio should preside over the proceedings (In re: Yaz/Yasmin Products Liability Litigation, MDL No. 2100, JPMDL; See August 2009, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Missouri Woman Says Use Of Bayer's Birth Control Caused Deep Vein Thrombosis</title>
<description>
<![CDATA[ST. LOUIS - A Missouri woman on Sept. 2 filed suit in federal court against the makers of Yaz and Yasmin, alleging that her use of the oral contraceptives for less than one year caused her to suffer deep vein thrombosis (DVT) in both of her legs in March 2006 (Anna Lorenz v. Bayer Corp., et al., No. 09-cv-1399, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Ohio Couple Says Birth Control Pills Caused Woman's Gallstones</title>
<description>
<![CDATA[NEW YORK - An Ohio couple says in a Sept. 3 lawsuit filed in New York federal court that the woman's use of Yaz and Yasmin caused her to develop gallstones that necessitated the removal of her gallbladder in September 2007 and that the makers of the birth control pills failed to adequately warn about the drugs' risks (Ambur Tiller, et al. v. Bayer Pharmaceuticals Corp., et al., No. 09-3838, E.D. N.Y.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Appeal Of Ruling Denying Motion To Dismiss Is Unnecessary, Plaintiffs Say</title>
<description>
<![CDATA[ST. LOUIS - Plaintiffs in the NuvaRing multidistrict litigation say in an Aug. 26 brief that the manufacturers' request to certify for appeal the order denying their motion to dismiss the master complaint should be denied because the ruling does not involve a controlling issue of law and would not advance the termination of the litigation (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>NuvaRing Makers Seek To Certify Order Denying Dismissal Of Master Complaint</title>
<description>
<![CDATA[ST. LOUIS - Organon Pharmaceuticals Inc. on Aug. 17 asked the federal judge presiding over the NuvaRing multidistrict litigation to certify for interlocutory appeal his recent order denying its motion to dismiss the plaintiff's master complaint for the Eighth Circuit U.S. Court of Appeals to determine if master complaints are entitled to substantial leniency and immune from heightened pleading requirements (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See August 2009, Page 14). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Current Discovery Process Is Efficient, NuvaRing Makers Tell MDL Court</title>
<description>
<![CDATA[ST. LOUIS - An order compelling the manufacturers of NuvaRing to provide documents to the plaintiffs every 30 days is unnecessary, the contraceptive makers say in a Sept. 8 response brief filed in the NuvaRing products liability multidistrict litigation court in the U.S. District Court for the Eastern District of Missouri, because every effort is being made to efficiently and quickly produce the voluminous amount of documents the plaintiffs are requesting (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964, E.D. Mo.; See related story in this issue). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%206-2 Mealeys Hormone Replacement Therapy 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Plaintiffs In NuvaRing MDL Ask For Accelerated Document Production</title>
<description>
<![CDATA[ST. LOUIS - Plaintiffs in the NuvaRing products liability multidistrict litigation say in an Aug. 24 motion to compel that the manufacturers should be required to produce a minimum number of documents every 30 days because the defendant companies' current system of producing documents is "simply not workable" and has resulted in significant delay in the process of conducting other discovery (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=6-2 Mealey's Hormone Replacement Therapy 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

</channel>

</rss>